Literature DB >> 22788788

Is Avastin the right choice of treatment for retinopathy of prematurity?

Anna Käll1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22788788     DOI: 10.1111/j.1651-2227.2012.02757.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


× No keyword cloud information.
  2 in total

1.  Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment.

Authors:  Girija Natarajan; Seetha Shankaran; Tracy L Nolen; Amaanti Sridhar; Kathleen A Kennedy; Susan R Hintz; Dale L Phelps; Sara B DeMauro; Waldemar A Carlo; Marie G Gantz; Abhik Das; Rachel G Greenberg; Noelle E Younge; Joseph M Bliss; Ruth Seabrook; Pablo J Sánchez; Myra H Wyckoff; Edward F Bell; Betty R Vohr; Rosemary D Higgins
Journal:  Pediatrics       Date:  2019-07-23       Impact factor: 7.124

Review 2.  Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis.

Authors:  Monika Kaushal; Abdul Razak; Waseemoddin Patel; Abdul Kareem Pullattayil; Ayush Kaushal
Journal:  J Perinatol       Date:  2020-12-08       Impact factor: 3.225

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.